AB | BC | MB | NB | NL | NS | NT | ON | PE | QC | SK | YT
Search National Drug Schedules Member Login

What's New

Pharmacy Technician Bridging Education Program-Course and PLAR exam schedules

Please note, this section will be updated periodically as the information becomes available.

 

      NEW:  Winter 2015 course and PLAR schedules now available

  Reminder: Courses and PLAR exams available in both English and French

    NOTE: Selkirk College registration deadline for all English and French courses beginning in January 2015 is December 11, 2014

____________________________
 

     NOUVEAU : Nouveau: Horaires de cours et d’examens ERA pour l’hiver 2015 maintenant disponibles

   Rappel :  Les cours et les examens ERA sont offerts en français et en anglais

  REMARQUE :  La date limite pour l’inscription aux cours (anglais et français) débutant en janvier 2015 au collège Selkirk est le 11 décembre 2014

 

Registration deadlines for all institutions are available on the Course and PLAR Schedules page.

Registration for all courses is conducted directly with the educational institution offering the program.

News Release / Communiqué de presse

NAPRA Officially Launches Pharmacists' Gateway Canada Program During Recent Board Meeting / Lancement officiel du Portail pour pharmaciens Canada par l'Association nationale des organismes de réglementation de la pharmacie (ANORP) lors d'une récente réunion du conseil 

News Release / Communiqué de presse

National Drug Schedules: Final Recommendations on topical hydrocortisone and hydrocortisone acetate in concentrations of 1% or less

The Interim Recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on September 16, 2014, subsequent to their meeting of September 7, 2014, were finalized effective October 17, 2014.
[> More]

Health Professional and Public Communication

REMINYL ER (galantamine hydrobromide) -  New Safety Information Regarding the Risk of Serious Skin Reactions - Janssen Inc.

Very rare cases of serious skin reactions have been reported in patients taking REMINYL ER. The Product Monograph has been updated to include this new safety information.

Health Canada Health Professional Communication

Health Canada Public Communication

Information Update

Health Canada reviewing possible safety concerns with certain long-term antiplatelet (blood thinner) therapy

Health Canada is aware of and will be reviewing new evidence on the safety of long-term use of the prescription blood-thinners clopidogrel (Plavix) and prasugrel (Effient). The benefits of clopidogrel and prasugrel in protecting against blood clots continue to outweigh their risks when used as directed.

Health Canada Information Update

Health Professional and Public Communication

IMOVANE (zopiclone) - New Dosage Recommendations to Minimize the Risk of Next-Day Impairment - sanofi-aventis Canada Inc.

Patients who take IMOVANE and other medicines to help them sleep may experience decreased ability to be alert the day after taking the medicine, even if they feel fully awake. This can cause next-day impairment of driving or other activities that require full mental alertness.

Health Canada Health Professional Communication

Health Canada Public Communication

 

NOW AVAILABLE!
SITE MAINTENANT DISPONIBLE!

Gateway for international
pharmacists
Portail pour pharmaciens
formés à l’étranger

 

 

 

National Pharmacy Technician Bridging Education Program

Students and educational institutions can find more information about NAPRA's newest program.


NDSAC Drug Scheduling Applications

Find information about the NDSAC process and how to prepare scheduling applications.

 

Blueprint for Pharmacy

Want to learn more? Click here to visit the website!